Your browser version may not work well with NCBI's Web applications. More information here...
1: J Am Acad Dermatol. 1996 Feb;34(2 Pt 2):365-7.Click here to read Links
Erratum in:
J Am Acad Dermatol 1996 Oct;35(4):587.
Comment in:
J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):501.

Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.

Webster GF, Knobler RL, Lublin FD, Kramer EM, Hochman LR.

Department of Dermatology, Jefferson Medical College, Philadelphia, USA.

Seven patients with multiple sclerosis who were receiving subcutaneous injections of recombinant interferon beta had pain followed by ulceration at the injection site. An eighth patient had a pustular flare of her usually mild psoriasis. No evidence of infection or contaminated medication was found.

PMID: 8655728 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Glatiramer Acetate (Copaxone, Avonex, Rebif, ...)

    How effective are disease-modifying drugs in the treatment of multiple sclerosis?

  • Interferon Beta-1b Injection (Betaseron® )

    Your doctor has ordered interferon beta-1b, a biologic response modifier. This medication is used to treat patients with multiple sclerosis (MS), a disease in which the nerves do not function properly and patients may ex...

  • Interferon beta-1a Subcutaneous Injection (Rebif® )

    Interferon beta-1a is used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis (MS, a disease in which the nerves do not function properly and pa...

  • Source: AHFS Consumer Medication Information